probenecid has been researched along with Brain Vascular Disorders in 3 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mrsulja, BB | 1 |
Mrsulja, BJ | 1 |
Spatz, M | 1 |
Klatzo, I | 1 |
Van Woert, MH | 1 |
Weintraub, MI | 1 |
Lhoda, F | 1 |
3 other studies available for probenecid and Brain Vascular Disorders
Article | Year |
---|---|
Brain serotonin after experimental vascular occlusion.
Topics: Animals; Cerebral Cortex; Cerebrovascular Disorders; Fenclonine; Gerbillinae; Hydroxyindoleacetic Ac | 1976 |
Predicting the response to levodopa.
Topics: Calcinosis; Capillaries; Central Nervous System; Cerebrospinal Fluid; Cerebrovascular Disorders; Dih | 1971 |
[Clinical aspects of gout].
Topics: Allopurinol; Cerebrovascular Disorders; Colchicine; Diagnosis, Differential; Diet Therapy; Female; G | 1970 |